Kiniksa Pharmaceuticals International annual gross profit
2021
2022
2023
2024
2025
Kiniksa Pharmaceuticals International Gross Profit Growth & History (KNSA)
Kiniksa Pharmaceuticals International's gross profit was $599.9M for fiscal 2025.
View full Kiniksa Pharmaceuticals International company overviewKiniksa Pharmaceuticals International annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $599.9M | $237.6M | +65.57% |
| 2024 | 2024-12-31 | $362.3M | $125.5M | +52.98% |
| 2023 | 2023-12-31 | $236.9M | $39.6M | +20.06% |
| 2022 | 2022-12-31 | $197.3M | $167.8M | +570.03% |
| 2021 | 2021-12-31 | $29.4M | — | — |
Kiniksa Pharmaceuticals International quarterly gross profit
Q2.21
Q3.21
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $132.0M | −$6.2M | −4.51% |
| Q1 2026 | 2026-03-31 | $193.5M | $73.6M | +61.34% |
| Q4 2025 | 2025-12-31 | $181.2M | $76.5M | +73.15% |
| Q3 2025 | 2025-09-30 | $160.6M | $68.5M | +74.36% |
| Q2 2025 | 2025-06-30 | $138.2M | $41.9M | +43.49% |
| Q1 2025 | 2025-03-31 | $119.9M | $50.6M | +73.10% |
| Q4 2024 | 2024-12-31 | $104.6M | $30.8M | +41.77% |
| Q3 2024 | 2024-09-30 | $92.1M | $34.1M | +58.92% |
| Q2 2024 | 2024-06-30 | $96.3M | $32.5M | +51.02% |
| Q1 2024 | 2024-03-31 | $69.3M | $28.0M | +67.70% |
| Q4 2023 | 2023-12-31 | $73.8M | — | — |
| Q3 2023 | 2023-09-30 | $58.0M | −$34.2M | −37.14% |
| Q2 2023 | 2023-06-30 | $63.8M | $41.8M | +190.63% |
| Q1 2023 | 2023-03-31 | $41.3M | — | — |
| Q3 2022 | 2022-09-30 | $92.2M | $82.9M | +888.40% |
| Q2 2022 | 2022-06-30 | $21.9M | $16.7M | +318.92% |
| Q3 2021 | 2021-09-30 | $9.3M | — | — |
| Q2 2021 | 2021-06-30 | $5.2M | — | — |
Kiniksa Pharmaceuticals International gross profit trends
Between the periods ended 2021-12-31 and 2025-12-31, Kiniksa Pharmaceuticals International's gross profit increased from $29.4M to $599.9M, a change of $570.4M. The latest reported quarter, Q2 2026, shows $132.0M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kiniksa Pharmaceuticals International source filings ↗